Clinical Trials Logo

Chest Wall Disorder clinical trials

View clinical trials related to Chest Wall Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT04279886 Completed - Chest Wall Disorder Clinical Trials

Three-dimensional Scanning of the Chest: a Comparison Between Three Different Imaging Modalities

Start date: February 20, 2020
Phase: N/A
Study type: Interventional

Recently, three-dimensional scanning of the torso has been proposed as an alternative for two-view chest radiographies and computed tomography to determine the severity of pectus excavatum without exposure to ionizing radiation. The range of three-dimensional scanning systems is broad with even varying systems being used within hospitals. Most of these scanning systems have been validated for accuracy and reproducibility, no comparison between these systems is known. In addition, severity measures of pectus excavatum, as well as other research outcomes, surgical planning techniques, and analysis methods are based on a single imaging system. It is subsequently essential to determine whether different imaging systems can be used interchangeably regarding accuracy and reproducibility. The aim of this study was to assess the reproducibility and accuracy between three commonly used three-dimensional scanning systems.

NCT ID: NCT04073758 Enrolling by invitation - Chest Wall Disorder Clinical Trials

Comparison of Analgesic Requirements in Patients Receiving Nuss Operation Using 2 Different Anesthetic Adjuvants

ARNRD
Start date: September 2, 2019
Phase: N/A
Study type: Interventional

Nowadays, general anaesthesia is carried under "balanced anesthesia technique" in which many anesthetic adjuvants are used simultaneously, including opioid analgesics in order to reduce the amount of inhalation agents. The most popular adjuvants used are remifentanil, which is an opioid analgesic, and dexmedetomidine. Both of these agents are short acting, can be infused with targeted concentrations, excreted shortly from the body with stable hemodynamics. Remifentanil, when infused for more than 2 hours, causes hyperalgesia to increase the amount of pain postoperatively as well as the amount of opioid analgesics. However, dexmedetomidine does not cause hyperalgesia and is known to have an opioid -sparing effect. In our center. In this study, we aim to compare the effects of remifentanil and dexmedetomidine on postoperative pain in patients undergoing Nuss procedure, which is a very painful operation on the chest wall.

NCT ID: NCT03171012 Recruiting - Stroke Clinical Trials

Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke

Start date: June 19, 2017
Phase: N/A
Study type: Interventional

Post-stroke hemiparesis causes sequelae in the limbs and also in the trunk and abdomen structures. The level of physical activity decreases and cardiorespiratory training(CRT) is indicated to this population to improve the functions of several systems (respiratory, cardiovascular, muscular). The application of Proprioceptive Neuromuscular Facility(PNF) would imply in the awareness and greater harmony of the functions performed by the trunk of this individual. The objective of this study is to evaluate the effects of respiratory and trunk characteristics of the PNF associated with Cardiorespiratory training in quality of life, gait, distance traveled, peak oxygen consumption, respiratory muscle strength, thoracic cavity volumes, mobility and diaphragmatic thickness of individuals with post stroke.

NCT ID: NCT01644162 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Ventilator Monitoring in Early Exacerbation Detection

Start date: July 2012
Phase: N/A
Study type: Interventional

The aim of this study is to determine whether respiratory disease exacerbations (a sudden worsening of symptoms) can be predicted by variables that are monitored by non-invasive ventilators (small machines that assist breathing) in patients requiring long term home ventilation. The investigators hypothesise that acute exacerbations of patients with respiratory disease and ventilatory failure will be predicted by changes in the respiratory variables monitored and stored by ventilators during chronic home ventilator use.

NCT ID: NCT01174316 Withdrawn - Clinical trials for Chronic Obstructive Pulmonary Disease

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

Start date: August 2010
Phase: N/A
Study type: Interventional

The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients admitted to hospital with acute exacerbation of chronic respiratory failure. The investigators hypothesise that autotitrating NIV will ventilate patients with acute exacerbations of chronic respiratory failure as effectively as standard NIV.

NCT ID: NCT00901485 Completed - Clinical trials for Neuromuscular Disease

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients

Start date: April 2009
Phase: N/A
Study type: Interventional

The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients with newly diagnosed nocturnal hypoventilation who have never experienced nocturnal, home NIV.

NCT ID: NCT00252252 Completed - Clinical trials for Neuromuscular Disease

AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation

Start date: November 2005
Phase: Phase 1
Study type: Interventional

The aim of the study is to compare the effects of a modified form (AutoVPAP) of the VPAP non-invasive ventilator versus standard VPAP ventilation on sleep quality and breathing during sleep in stable patients with nocturnal hypoventilation due to restrictive ventilatory disorders (eg. neuromuscular disease or chest wall disorder).